- Home
- TEO vs DNTH Comparison
TEO vs DNTH Comparison
Compare TEO & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEO | DNTH |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | Argentina | United States |
| Employees | 27818 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.5B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | TEO | DNTH |
|---|---|---|
| Price | $13.08 | $93.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | $12.30 | ★ $121.00 |
| AVG Volume (30 Days) | 726.8K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,036,000.00 |
| Revenue This Year | $4.91 | N/A |
| Revenue Next Year | $1.58 | $29.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.43 | $18.08 |
| 52 Week High | $16.34 | $98.70 |
Technical Indicators
Market Signals| Indicator | TEO | DNTH |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 57.77 |
| Support Level | $13.07 | $79.27 |
| Resistance Level | $13.50 | $96.50 |
| Average True Range (ATR) | 0.64 | 5.29 |
| MACD | -0.18 | 1.01 |
| Stochastic Oscillator | 21.90 | 76.24 |
Price Performance
Historical ComparisonAbout TEO Telecom Argentina SA
Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company operates in segments: ICT Services provided in Argentina: Personal Network; ICT Services provided in Argentina - TMA Network; and Other segments..
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.